CN115057803B - S-(甲基-d3)苯硫醚类物质的合成方法及其应用 - Google Patents
S-(甲基-d3)苯硫醚类物质的合成方法及其应用 Download PDFInfo
- Publication number
- CN115057803B CN115057803B CN202210899216.0A CN202210899216A CN115057803B CN 115057803 B CN115057803 B CN 115057803B CN 202210899216 A CN202210899216 A CN 202210899216A CN 115057803 B CN115057803 B CN 115057803B
- Authority
- CN
- China
- Prior art keywords
- mmol
- hours
- cdcl
- methyl
- nmr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 methyl-d Chemical class 0.000 title claims abstract description 21
- LTYMSROWYAPPGB-UHFFFAOYSA-N diphenyl sulfide Chemical compound C=1C=CC=CC=1SC1=CC=CC=C1 LTYMSROWYAPPGB-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 239000000126 substance Substances 0.000 title claims abstract description 14
- 238000001308 synthesis method Methods 0.000 title claims description 6
- 238000006243 chemical reaction Methods 0.000 claims abstract description 83
- 239000011734 sodium Substances 0.000 claims abstract description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 9
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 9
- 125000001424 substituent group Chemical group 0.000 claims abstract description 9
- 239000003960 organic solvent Substances 0.000 claims abstract description 8
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims abstract description 8
- 239000002904 solvent Substances 0.000 claims description 51
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 45
- 229910052757 nitrogen Inorganic materials 0.000 claims description 42
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 33
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 4
- 229910052786 argon Inorganic materials 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 58
- 238000000034 method Methods 0.000 abstract description 15
- 239000000758 substrate Substances 0.000 abstract description 7
- 150000001503 aryl iodides Chemical class 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 230000001035 methylating effect Effects 0.000 abstract description 3
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- 125000002355 alkine group Chemical class 0.000 abstract 1
- 238000007086 side reaction Methods 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 117
- 239000012074 organic phase Substances 0.000 description 92
- 239000012299 nitrogen atmosphere Substances 0.000 description 77
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 61
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- 239000000047 product Substances 0.000 description 51
- 239000012300 argon atmosphere Substances 0.000 description 40
- 238000001816 cooling Methods 0.000 description 39
- 239000012043 crude product Substances 0.000 description 39
- 238000010898 silica gel chromatography Methods 0.000 description 39
- 238000003756 stirring Methods 0.000 description 34
- 239000010409 thin film Substances 0.000 description 32
- 238000000926 separation method Methods 0.000 description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 25
- 239000007788 liquid Substances 0.000 description 24
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 23
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- 238000002390 rotary evaporation Methods 0.000 description 18
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 17
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 17
- MQRWBMAEBQOWAF-UHFFFAOYSA-N acetic acid;nickel Chemical compound [Ni].CC(O)=O.CC(O)=O MQRWBMAEBQOWAF-UHFFFAOYSA-N 0.000 description 17
- 229940078494 nickel acetate Drugs 0.000 description 17
- 238000002955 isolation Methods 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 239000007787 solid Substances 0.000 description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- 238000010926 purge Methods 0.000 description 12
- 229910052740 iodine Inorganic materials 0.000 description 11
- 239000011630 iodine Substances 0.000 description 11
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 10
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 10
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 7
- 150000001345 alkine derivatives Chemical class 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 229910052717 sulfur Inorganic materials 0.000 description 7
- 239000011593 sulfur Substances 0.000 description 7
- 230000011987 methylation Effects 0.000 description 6
- 238000007069 methylation reaction Methods 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 159000000000 sodium salts Chemical class 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- QNEFNFIKZWUAEQ-UHFFFAOYSA-N carbonic acid;potassium Chemical compound [K].OC(O)=O QNEFNFIKZWUAEQ-UHFFFAOYSA-N 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 125000004055 thiomethyl group Chemical group [H]SC([H])([H])* 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052805 deuterium Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000006880 cross-coupling reaction Methods 0.000 description 2
- 150000001975 deuterium Chemical group 0.000 description 2
- 125000004431 deuterium atom Chemical group 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229940095102 methyl benzoate Drugs 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000006578 reductive coupling reaction Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- PVDVRZVOIACFTC-UHFFFAOYSA-M sodium;naphthalen-2-yl-oxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical group [Na+].C1=CC=CC2=CC(S(=O)(=O)[S-])=CC=C21 PVDVRZVOIACFTC-UHFFFAOYSA-M 0.000 description 2
- YLEDCRWLOAQBDP-VOTSOKGWSA-N 1-[(e)-2-iodoethenyl]-4-methoxybenzene Chemical compound COC1=CC=C(\C=C\I)C=C1 YLEDCRWLOAQBDP-VOTSOKGWSA-N 0.000 description 1
- ZCYLOWOVAYQNAA-UHFFFAOYSA-N 1-iodo-4-prop-2-enoxybenzene Chemical compound IC1=CC=C(OCC=C)C=C1 ZCYLOWOVAYQNAA-UHFFFAOYSA-N 0.000 description 1
- SODQFLRLAOALCF-UHFFFAOYSA-N 1lambda3-bromacyclohexa-1,3,5-triene Chemical compound Br1=CC=CC=C1 SODQFLRLAOALCF-UHFFFAOYSA-N 0.000 description 1
- LVMOKIQHDKDNBI-UHFFFAOYSA-N 3-(trifluoromethyl)benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC(C(F)(F)F)=C1 LVMOKIQHDKDNBI-UHFFFAOYSA-N 0.000 description 1
- MJHLPKWONJUCFK-UHFFFAOYSA-N 3-ethynylthiophene Chemical compound C#CC=1C=CSC=1 MJHLPKWONJUCFK-UHFFFAOYSA-N 0.000 description 1
- NDQXBRCPYKGVED-UHFFFAOYSA-N 3-iodoquinoline Chemical compound C1=CC=CC2=CC(I)=CN=C21 NDQXBRCPYKGVED-UHFFFAOYSA-N 0.000 description 1
- CXWLXKZIXLOBCC-UHFFFAOYSA-N 5-chloro-2-iodopyridine Chemical group ClC1=CC=C(I)N=C1 CXWLXKZIXLOBCC-UHFFFAOYSA-N 0.000 description 1
- LNRVLSJOGUTLDU-UHFFFAOYSA-N 5-iodo-1-benzofuran Chemical compound IC1=CC=C2OC=CC2=C1 LNRVLSJOGUTLDU-UHFFFAOYSA-N 0.000 description 1
- TVQLYTUWUQMGMP-UHFFFAOYSA-N 5-iodo-1h-indole Chemical compound IC1=CC=C2NC=CC2=C1 TVQLYTUWUQMGMP-UHFFFAOYSA-N 0.000 description 1
- WKTASELJZCIVBR-UHFFFAOYSA-N 6-iodoquinoline Chemical compound N1=CC=CC2=CC(I)=CC=C21 WKTASELJZCIVBR-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical class CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000012039 electrophile Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- XZIAFENWXIQIKR-UHFFFAOYSA-N ethyl 4-bromobenzoate Chemical compound CCOC(=O)C1=CC=C(Br)C=C1 XZIAFENWXIQIKR-UHFFFAOYSA-N 0.000 description 1
- YCBJOQUNPLTBGG-UHFFFAOYSA-N ethyl 4-iodobenzoate Chemical compound CCOC(=O)C1=CC=C(I)C=C1 YCBJOQUNPLTBGG-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- OIRDBPQYVWXNSJ-UHFFFAOYSA-N methyl trifluoromethansulfonate Chemical class COS(=O)(=O)C(F)(F)F OIRDBPQYVWXNSJ-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002815 nickel Chemical class 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- NODGRWCMFMEGJH-UHFFFAOYSA-N p-ethylacetophenone Chemical compound CCC1=CC=C(C(C)=O)C=C1 NODGRWCMFMEGJH-UHFFFAOYSA-N 0.000 description 1
- KZQFPRKQBWRRHQ-UHFFFAOYSA-N phenyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OC1=CC=CC=C1 KZQFPRKQBWRRHQ-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000012354 sodium borodeuteride Substances 0.000 description 1
- RMYVMKHVFXTKPF-UHFFFAOYSA-N tert-butyl 5-iodoindole-1-carboxylate Chemical compound IC1=CC=C2N(C(=O)OC(C)(C)C)C=CC2=C1 RMYVMKHVFXTKPF-UHFFFAOYSA-N 0.000 description 1
- MFPWEWYKQYMWRO-UHFFFAOYSA-N tert-butyl carboxy carbonate Chemical compound CC(C)(C)OC(=O)OC(O)=O MFPWEWYKQYMWRO-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical class [H]S* 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Substances CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- C07C381/04—Thiosulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了S‑(甲基‑d3)苯硫醚类物质的合成方法及其应用。本发明首先将不同取代基的磺酸钠加入到容器中,再加入D3‑对甲苯磺酰甲酯和有机溶剂,常温下反应2~10小时,得到S‑(甲基‑d3)苯硫醚类物质。本发明还提供了S‑(甲基‑d3)苯硫醚类物质作为亲电的三氘甲基化试剂的应用,应用底物为芳基碘衍生物或端炔衍生物。本发明的产品作为一种亲电的三氘甲基化试剂,其结构稳定,易于存放,反应活性高。本发明方法底物溶解性好、适用性广,反应产率高。本发明方法副反应少,绿色、高效。
Description
技术领域
本发明属于化学技术领域,涉及S-(甲基-d3)苯硫醚类物质的合成方法及其应用,应用于在不同催化剂下与不同的亲电试剂和亲核试剂反应制备硫氘代甲基化的产物。
背景技术
氘原子作为氢原子的生物电子等排体,因在药物发现和开发中的广泛应用而为各类化学家所熟知。它的重要特点是C-D键键长较短,振动频率较低,比C-H键解离能更高,可直接影响某些药物分子的吸收、分布、代谢和排泄,从而提高药物的有效性、耐受性和安全性。所以,氘原子对含氢的药物分子进行较小的修饰,以达到在不改变原有药物的优势作用的情况下,降低药物毒性,改变药代动力学,并增强所需的生物药物或物理特性。硫氘代甲基作为含氘原子取代基重要的一员,广泛存在于众多天然产物和药物中,在提高分子的生物活性和物理性质方面起着至关重要的作用。由于氘原子的存在,且对含有硫氘代甲基的分子而言,在高产率地制备该类化合物的同时,得到优秀的氘化率(>99%)是目前该领域存在的难点与挑战。
目前,合成含有硫氘代甲基的有机分子主要是通过剧毒且具有恶臭味的苯硫酚或者硫醇底物与亲电氘代甲基化反应,而这种策略往往需要特点的底物,官能团兼容性较差,同时氘代甲基化试剂种类的不足也制约着这种方法的进一步应用(Wang,M.Y.;Zhao,Y.F.;Zhao.Y.;Shi,Z.Z.Science Adv,2020,6,1-7)。直接的硫氘代甲基化方法克服了上述缺点,底物的普适性大大增强。在这种策略中,亲电的硫氘代甲基化试剂的开发和应用是一种行之有效的方法,但高效的亲电试剂种类十分缺少,通过氘代DMSO或者氘代硼氢化钠制备相应的亲电硫氘代甲基化试剂,需要大约40当量的氘代DMSO,成本非常高昂,同时氘化率最高只能达到97%。在后续的硫氘代甲基的直接引入中,产物的氘化率也只能达到97%,无法满足相关含硫氘代药物的需求(Huang,C.M.;Li,J.;Ai,J.J.;Liu,X.Y.;Rao,W.D.;Wamg,S.Y.Org.Lett,2020,22,9128-9132)。从廉价易得的氘代甲醇出发制备的氘代三氟甲基磺酸甲酯,以“一锅法”的形式可以制备高氘化率的亲电硫氘代甲基化试剂,但需要加热以及额外的添加剂促进其合成(Xiao,Xiao.;Huang,Y,Q.;Tian,H.Y.;Bai.J.;Cheng,F.;Wang.X.;Ke,M.L.;Chen,F.E.Chem Commun.2022,58,3015-3018.)。
以廉价易得的氘源作为起始原料,发展一种结构可调、活性可控的高活性亲电硫氘代试剂的合成方法,同时研究和拓展这类化合物在高效直接引入硫氘代基团具有重要的意义。
发明内容
本发明的一个目的在于提供一种S-(甲基-d3)苯硫醚类物质的合成方法。
首先采用现有方法(专利号:201110064696.0),以氘代甲醇作为初始物,制备D3-对甲苯磺酰甲酯;然后合成S-(甲基-d3)苯硫醚类物质。
步骤(1)常温下,将不同取代基的磺酸钠加入到容器中,再加入D3-对甲苯磺酰甲酯和有机溶剂;
所述的磺酸钠为萘-2-硫代磺酸钠,结构式为或喹啉-8-硫代磺酸钠,结构式为/>或结构式为/>的磺酸钠,其中取代基R1为烷基、硝基、氰基、卤素、三氟甲基中的一种,取代位为2或3或4;
所述的有机溶剂为N,N-二甲基甲酰胺溶剂或N,N-二甲基乙酰胺溶剂,浓度为0.1~1M;
反应体系中,加入的磺酸钠与D3-对甲苯磺酰甲酯的摩尔比为1.5:1,每mmol的D3-对甲苯磺酰甲酯对应加入1~10ml有机溶剂。
步骤(2)常温下反应2~10小时,如下:
得到S-(甲基-d3)苯硫醚类物质,R2为/>
进一步,反应在氮气或氩气保护下进行。
本发明另一个目的是提供利用以上方法制备的S-(甲基-d3)苯硫醚类物质作为亲电的三氘甲基化试剂的应用,应用底物为芳基碘衍生物或端炔衍生物。
所述的芳基碘衍生物为5-氯-2-碘吡啶,结构式为或6-碘喹啉,结构式为/>或3-碘喹啉,结构式为/>或5-碘-1H-吲哚,结构式为/>或5-碘-1H-吲哚-1-羧酸叔丁酯,结构式为/>或5-碘苯并呋喃,结构式为或(E)-1-(2-碘乙烯基)-4-甲氧基苯,结构式为/>
或结构式为的芳基碘衍生物,其中取代基R3为胺基、羟基、醛基、卤素、酯基、对甲苯磺酰氧基、叔丁基二碳酸酯、酰胺基中的一种。
所述的端炔衍生物为丁-3-炔-1-基-2-噻吩甲酸甲酯,结构式为或3-乙炔基噻吩,结构式为/>
或结构式为的端炔衍生物,其中取代基R4为胺基、甲氧基、羰基、卤素、酯基中的一种;
或结构式为的端炔衍生物,其中取代基R5为卤素。
本方法克服了以往方法中起始原料昂贵、试剂合成繁琐以及试剂活性不高的缺点,以廉价易得的氘代甲醇作为初始物,制备了一类S-氘代甲基-芳基磺酰硫酯类化合物,通过调节试剂骨架中的不同基团,进一步实现了这类亲电硫氘代试剂的反应活性调控。同时,开发了两种在金属盐催化下其与芳基碘苯的还原偶联反应、与末端炔烃下的交叉偶联反应。
本发明具有以下有益效果:
(1)本发明成本低廉,从氘代甲醇出发,经过简单的两步反应,实现了在室温以及无外加添加剂的情况下,且无需经过繁琐的柱层析分离即可得到氘代硫甲基试剂。
(2)本发明制备了一类在试剂骨架中引入不同取代基的氘代硫甲基试剂,实现了结构可调、活性可控。
(3)本发明开发了在镍盐和配体作用下上述氘代硫甲基试剂与芳基碘苯的还原偶联反应,实现了C(sp2)-SCD3化学键的构建;开发了在铜盐和配体作用下上述氘代硫甲基试剂与末端炔烃的交叉偶联反应,实现了C(sp1)-SCD3化学键的构建。
具体实施方式
以下结合具体实施例对本发明的制备方法和具体应用做进一步的说明,但下述实例绝非对本发明有任何限制。
首先采用现有方法制备D3-对甲苯磺酰甲酯,然后制备S-(甲基-d3)苯硫醚类物质。
制备实施例1.
具体是:
将已经在120℃的烘箱内烘1-2小时的100mL圆底烧瓶,冷却后放入磁子,在氮气或氩气氛围下抽换气三次,加入37.5mmol的4-甲苯硫代磺酸钠盐在氮气或氩气氛围下抽换气三次,加入25.0mmol的试剂和50mL的超干N,N-二甲基甲酰胺溶剂,于室温下搅拌反应6h,将反应液倾入50mL的水中,有机相用乙酸乙酯萃取(50mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以94%的分离收率得到白色固体目标产物,且氘化率>99%。1H NMR(400MHz,CDCl3)δ7.79(2H,d,J=8.3Hz),7.34(2H,d,J=8.4Hz),2.44(3H,s);13CNMR(101MHz,CDCl3)δ144.9,140.9,129.9,127.2,21.7,17.9–17.1(m,C-D3)。
制备实施例2.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的4-硝基硫代磺酸钠盐在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和30.0mL的超干N,N-二甲基甲酰胺溶剂,于室温下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以75%的分离收率得到淡黄色固体目标产物,且氘化率>99%。M.p.=94.6–95.9℃;IR(thin film)1526(s),1333(m),1142(s),1078(m),855(m),732(s),681(s)cm-1;1H NMR(400MHz,CDCl3)δ8.42(2H,d,J=8.9Hz),8.12(2H,d,J=8.9Hz);13C NMR(101MHz,CDCl3)δ150.6,148.8,128.4,124.8,18.2–17.4(m,C-D3);HRMS(ESI+)[M+H]+计算值C7H5D3NO4S2:237.0078,实测值:237.0078。
制备实施例3.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的4-氰基硫代磺酸钠盐在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和15.0mL的超干N,N-二甲基乙酰胺溶剂,于室温下搅拌反应3h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以83%的分离收率得到白色固体目标产物,且氘化率>99%。M.p.=91.9–92.7℃;IR(thin film)1325(m),1142(s),1075(m),834(m),783(w),622(s)cm-1;1H NMR(400MHz,CDCl3)δ8.04(2H,d,J=8.6Hz),7.88(2H,d,J=8.6Hz);13C NMR(101MHz,CDCl3)δ147.4,133.3,127.7,117.4,117.1,18.5–17.4(m,C-D3);HRMS(ESI+)[M+H]+计算值C8H5D3NO2S2:217.0179,实测值:217.0185。
制备实施例4.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的4-氯硫代磺酸钠盐在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和10.0mL的超干N,N-二甲基甲酰胺溶剂,于室温下搅拌反应4h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以81%的分离收率得到白色固体目标产物,且氘化率>99%。M.p.=34.7–35.9℃;IR(thin film)1576(m),1473(m),1394(m),1321(s),1820(m),1142(s),1076(s),1012(m),824(m),747(s),699(m)cm-1;1H NMR(400MHz,CDCl3)δ7.85(2H,dd,J=8.7,2.0Hz),7.53(dd,J=8.7,1.9Hz,2H);13C NMR(101MHz,CDCl3)δ142.1,140.4,129.7,128.6,18.1–17.2(m,C-D3);HRMS(ESI+)[M+Na]+计算值C7H4D3ClO2S2Na:247.9656;实测值:247.9665。
制备实施例5.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的4-氟苯硫代磺酸钠盐在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和6.0mL的超干N,N-二甲基甲酰胺溶剂,于室温下搅拌反应6h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以80%的分离收率得到白色固体目标产物,且氘化率>99%。M.p.=45.8–46.5℃;IR(thin film)1584(m),1489(m),1325(m),1290(m),1229(m),1137(s),1098(m),836(s),1137(s),708(m),654(s)cm-1;1H NMR(400MHz,CDCl3)δ7.98–7.94(2H,m),7.28–7.23(2H,m);13C NMR(101MHz,CDCl3)δ165.6(d,JC-F=257.8Hz),139.8(d,JC-F=3.1Hz),130.0(d,JC-F=9.6Hz),116.6(d,JC-F=22.8Hz),18.0–17.2(m,C-D3);19F NMR(471MHz,CDCl3)δ-102.95–-102.99(1F,m).HRMS(ESI+)[M+H]+计算值C7H5D3ClO2S2:210.0133,实测值:210.0128。
制备实施例6.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的4-三氟甲基苯硫代磺酸钠盐在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和6.0mL的超干N,N-二甲基乙酰胺溶剂,于室温下搅拌反应6h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以79%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)1404(w),1320(s),1131(s),1107(m),1081(m),1061(s),1016(m),843(m),709(s),611(s)cm-1;1H NMR(400MHz,CDCl3)δ8.06(2H,d,J=8.2Hz),7.84(2H,d,J=8.3Hz);13C NMR(101MHz,CDCl3)δ146.9,135.1(q,JC-F=33.2Hz),127.6,126.6(q,JC-F=3.6Hz),123.1(q,JC-F=274.1Hz),18.1–17.2(m,C-D3);19F NMR(471MHz,CDCl3)δ-63.2.HRMS(ESI+)[M+H]+计算值C8H5D3F3O2S2:260.0101,实测值:260.0105。
制备实施例7.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的3-氯苯硫代磺酸钠盐在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和5.0mL的超干N,N-二甲基甲酰胺溶剂,于室温下搅拌反应7h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以72%的分离收率得到黄色油状液体目标产物,且氘化率>99%。IR(thin film)1460(w),1409(w),1327(m),1143(s),1075(m),788(m),666(s)cm-1;1H NMR(400MHz,CDCl3)δ7.90(1H,s),7.81(1H,d,J=7.9Hz),7.61(1H,d,J=8.1Hz),7.54–7.50(1H,m);13C NMR(101MHz,CDCl3)δ145.2,135.6,134.0,130.7,127.2,125.2,18.0–17.5(m,C-D3);HRMS(ESI+)[M+H]+计算值C7H5D3ClO2S2:225.9837,实测值:225.9847。
制备实施例8.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的2-氟苯硫代磺酸钠盐在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和6.0mL的超干N,N-二甲基甲酰胺溶剂,于室温下搅拌反应6h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以78%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)1596(w),1473(s),1328(s),1266(m),1227(w),1144(s),1120(s),1067(m),826(m),762(s),712(m),685(s)cm-1;1H NMR(400MHz,CDCl3)δ7.92–7.87(1H,m),7.69–7.63(1H,m),7.34–7.25(2H,m);13C NMR(101MHz,CDCl3)δ158.8(d,JC-F=259.6Hz),136.2(d,JC-F=8.3Hz),131.7(d,JC-F=13.3Hz),129.8,124.4(d,JC-F=4.2Hz),117.9(d,JC-F=21.1Hz),18.2–17.6(m,C-D3);19F NMR(471MHz,CDCl3)δ-106.95–-107.0(1F,m).HRMS(ESI+)[M+H]+计算值C7H5D3FO2S2:210.0133;实测值:210.0142。
制备实施例9.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的萘-2-硫代磺酸钠在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和6.0mL的超干N,N-二甲基甲酰胺溶剂,于室温下搅拌反应6h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以84%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thinfilm)1318(s),1142(s),1124(s),1066(m),852(w),822(m),750(m),652(s),636(m),611(m)cm-1;1H NMR(400MHz,CDCl3)δ8.46(1H,s),8.02–7.99(2H,m),7.95–7.90(2H,m),7.71–7.63(2H,m);13C NMR(101MHz,CDCl3)δ140.3,135.2,131.8,130.0,129.6,129.5,128.7,128.0,128.0,122.0,17.9–17.4(m,C-D3);HRMS(ESI+)[M+H]+计算值C11H8D3O2S2:242.0383;实测值:242.0392。
制备实施例10.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的3-三氟甲基苯硫代磺酸钠盐在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和3.0mL的超干N,N-二甲基乙酰胺溶剂,于室温下搅拌反应10h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以80%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)1323(s),1127(s),1099(s),1069(s),805(m),719(m),692(m),651(m),638(s)cm-1;1H NMR(400MHz,CDCl3)δ8.18(1H,s),8.12(1H,d,J=8.0Hz),7.91(1H,d,J=7.8Hz),7.76–7.72(1H,m);13C NMR(101MHz,CDCl3)δ144.8,132.0(q,JC-F=33.9Hz),130.4(q,JC-F=3.5Hz),130.3,130.2,124.1(q,JC-F=3.9Hz),123.0(q,JC-F=274.1Hz),18.1–17.2(m,C-D3);19F NMR(471MHz,CDCl3)δ-62.9.HRMS(ESI+)[M+H]+计算值C8H5D3F3O2S2:260.0101,实测值:260.0106。
制备实施例11.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的喹啉-8-硫代磺酸钠在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和6.0mL的超干N,N-二甲基甲酰胺溶剂,于室温下搅拌反应6h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以62%的分离收率得到白色固体目标产物,且氘化率>99%。M.p.=116.6–117.7℃;IR(thin film)1493(w),1312(s),1160(w),1115(s),830(s),787(s),762(m),669(s),629(s)cm-1;1H NMR(400MHz,CDCl3)δ9.15(1H,dd,J=4.3,1.8Hz),8.43(1H,dd,J=7.4,1.4Hz),8.27(1H,dd,J=8.3,1.8Hz),8.10(1H,dd,J=8.2,1.4Hz),7.65(1H,dd,J=8.2,7.4Hz),7.58(1H,dd,J=8.3,4.2Hz);13C NMR(101MHz,CDCl3)δ151.2,143.0,140.4,136.5,134.5,130.6,129.1,124.9,122.3,19.2–18.4(m,C-D3);HRMS(ESI+)[M+H]+计算值C10H7D3NO2S2:243.0336;实测值:243.0330。
制备实施例12.
产物为具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入4.5mmol的3-氟苯硫代磺酸钠盐在氮气或氩气氛围下抽换气三次,加入3.0mmol的试剂和6.0mL的超干N,N-二甲基甲酰胺溶剂,于室温下搅拌反应6h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以73%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)1591(w),11471(m),1425(w),1324(s),1304(m),1268(w),1224(m),1132(s),1081(m),1000(w),885(m),867(m),800(m),690(m),672(m),612(m)cm-1;1H NMR(400MHz,CDCl3)δ7.72(1H,d,J=7.9Hz),7.63–7.61(1H,m),7.59–7.54(1H,m),7.38–7.33(1H,m);13C NMR(101MHz,CDCl3)δ162.3(d,JC-F=254.0Hz),145.4(d,JC-F=6.7Hz),131.2(d,JC-F=7.5Hz),122.9(d,JC-F=3.6Hz),121.1(d,JC-F=21.4Hz),114.4(d,JC-F=24.9Hz),18.1–17.2(m,C-D3);19FNMR(471MHz,CDCl3)δ-108.7–-108.8(1F,m).HRMS(ESI+)[M+H]+计算值C7H5D3FO2S2:210.0133;实测值:210.0125。
按照实施例1-12方法制备的S-(甲基-d3)苯硫醚类物质作为亲电的三氘甲基化试剂的应用,应用底物为芳基碘衍生物或端炔衍生物。
应用实施例1.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的4-碘苯甲醚、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以93%的分离收率得到无色油状液体目标产物,且氘化率>99%。1H NMR(400MHz,CDCl3)δ7.26(2H,d,J=8.9Hz),6.84(2H,d,J=8.1Hz),3.77(3H,s);13C NMR(101MHz,CDCl3)δ158.2,130.2,128.7,114.7,55.4,17.8–17.0(m,C-D3)。
应用实施例2.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的4-碘苯甲酸甲酯、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以89%的分离收率得到白色固体目标产物,且氘化率>99%。M.p.=79.4–81.4℃;IR(thin film)1706(s),1593(m),1434(m),1402(m),1187(m),1114(s),1011(m),967(m),837(m),757(s),670(m)cm-1;1HNMR(400MHz,CDCl3)δ7.92(2H,d,J=8.5Hz),7.23(2H,d,J=8.4Hz),3.88(3H,s);13C NMR(101MHz,CDCl3)δ166.9,145.5,129.9,126.3,124.9,52.1,14.6–13.8(m,C-D3);HRMS(ESI+)[M+H]+计算值C9H8D3O2S:186.0663,实测值:186.0665。
应用实施例3.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的(E)-1-(2-碘伏基)-4-甲氧基苯、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以77%的分离收率得到白色固体目标产物,且氘化率>99%。M.p.=67.0–69.2℃;IR(thinfilm)1593(m),1508(s),1464(w),1305(w),1258(s),1238(m),1176(m),1032(s),928(s),837(s),785(s),743(w)cm-1;1H NMR(400MHz,CDCl3)δ7.14(2H,d,J=8.60Hz),6.75(2H,d,J=8.6Hz),6.52(1H,d,J=15.4Hz),6.20(1H,d,J=15.4Hz),3.70(3H,s);13C NMR(101MHz,CDCl3)δ158.7,130.2,126.7,124.9,123.3,114.2,55.4,14.8–14.1(m,C–D3);HRMS(ESI+)[M+H]+计算值C10H10D3OS:184.0870,实测值:184.0863。
应用实施例4.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的4-碘苯甲苯、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以73%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)2917(m),1697(s),1592(s),1561(m),1216(m),1171(m),1095(s),966(s),911(m),833(s),812(s)cm-1;1H NMR(400MHz,CDCl3)δ9.91(1H,s),7.76(2H,d,J=8.5Hz),7.31(2H,d,J=8.4Hz);13C NMR(101MHz,CDCl3)δ191.4,148.0,133.0,130.1,125.3,13.9–14.3(m,C-D3);HRMS(ESI+)[M+H]+计算值C8H5D3NaOS:178.0376,实测值:178.0369。
应用实施例5.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的1-氯-4-碘苯、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以80%的分离收率得到无色油状液体目标产物,且氘化率>99%。1H NMR(400MHz,CDCl3)δ7.24(2H,d,J=8.6Hz),7.16(2H,d,J=8.7Hz);13C NMR(101MHz,CDCl3)δ137.1,130.9,129.0,128.0,15.0–15.9(m,C-D3)。
应用实施例6.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的2-(4-碘苯基)-4,4,5,5-四甲基-1,3,2-二氧苯甲醛、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干的甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用沙星漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以61%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thinfilm)2977(w),1597(m),1394(m),1357(s),1144(m),1102(s),1015(w),962(w),858(m),818(m),727(w),652(m)cm-1;1H NMR(400MHz,CDCl3)δ7.71(2H,d,J=8.3Hz),7.22(2H,d,J=8.4Hz),1.34(12H,s);13C NMR(101MHz,CDCl3)δ142.7,135.2,130.0,125.1,83.9,14.7–14.3(m,C-D3);HRMS(EI+)[M+H]+计算值C13H17D3BO2S:254.1460,实测值:254.1461。
应用实施例7.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的5-碘代-1H-吲哚、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以83%的分离收率得到黄色油状液体目标产物,且氘化率>99%。IR(thin film)3409(w),1453(m),1412(w),1307(m),1094(w),890(w),799(w),757(s),722(s)cm-1;1H NMR(400MHz,CDCl3)δ8.08(1H,brs);7.64(1H,s);7.26(1H,d,J=8.4Hz),7.21(1H,d,J=8.5Hz),7.14(1H,s),6.48(1H,s);13C NMR(101MHz,CDCl3)δ134.5,128.7,127.9,125.0,124.0,121.2,117.7,102.2,18.4–17.6(m,C-D3);HRMS(ESI+)[M+H]+计算值C9H7D3NS:167.0717,实测值:167.0736。
应用实施例8.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的5-碘-1H-吲哚-1-羧酸叔丁酯、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以91%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)1730(s),1450(s),1364(s),1340(s),1277(m),1247(s),1158(s),1133(s),1085(s),1022(s),854(w),790(w),761(s),721(m),613(w)cm-1;1H NMR(400MHz,CDCl3)δ8.07(1H,d,J=7.4Hz),7.59(1H,d,J=3.2Hz),7.50(1H,d,J=1.6Hz),7.29(1H,dd,J=1.8,8.7Hz),6.51(1H,d,J=3.6Hz),1.68(9H,s);13C NMR(101MHz,CDCl3)δ149.7,133.5,131.7,131.4,126.6,124.8,120.1,115.6,106.8,83.9,28.3,17.1–16.7(m,C-D3);HRMS(ESI+)[M+H]+计算值C14H14D3NNaO2S:289.1061,实测值:289.1067。
应用实施例9.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的1-氯-4-碘苯、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以81%的分离收率得到白色固体目标产物,且氘化率>99%。1H NMR(400MHz,CDCl3)δ7.83(1H,s),7.42(2H,d,J=8.6Hz),7.19(2H,d,J=8.6Hz),2.14(3H,s);13C NMR(101MHz,CDCl3)δ168.7,135.6,133.6,127.9,120.8,24.6。
应用实施例10.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的5-碘苯并呋喃、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以89%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)1447(s),1261(m),1173(s),1132(m),1110(s),1030(s),874(m),802(m),760(s),731(s),697(m)cm-1;1H NMR(400MHz,CDCl3)δ7.62(1H,d,J=2.2Hz),7.56(1H,d,J=1.9Hz),7.44(1H,d,J=8.6Hz),7.28(1H,dd,J=2.0,8.6Hz),6.72(1H,dd,J=1.0,2.2Hz);13CNMR(101MHz,CDCl3)δ153.6,145.8,131.9,128.4,125.2,120.8,111.9,106.3,17.6–17.2(m,C-D3);HRMS(ESI+)[M+H]+计算值C9H7D3NS:168.0557,实测值:168.0555。
应用实施例11.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的3-碘喹啉、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以65%的分离收率得到黄色固体目标产物,且氘化率>99%。M.p.=38.9–40.2℃;IR(thin film)1706(s),1593(m),1434(m),1402(m),1187(m),1114(s),1011(m),967(m),837(m),757(s),670(m)cm-1;1H NMR(400MHz,CDCl3)δ8.79(1H,d,J=2.4Hz),8.05(1H,d,J=8.4Hz),7.87(1H,d,J=2.2Hz),7.71(1H,d,J=8.4Hz),7.65–7.61(1H,m),7.54–7.50(1H,m);13C NMR(101MHz,CDCl3)δ150.0,145.9,132.7,131.2,129.3,128.7,128.4,127.3,126.8,15.6–15.0(m,C-D3);HRMS(ESI+)[M+H]+计算值C10H7D3NS:179.0717,实测值:179.0710。
应用实施例12.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的6-碘喹啉、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干的甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以42%的分离收率得到黄色固体目标产物,且氘化率>99%。M.p.=43.1–43.8℃;IR(thinfilm)1584(w),1484(w),1343(w),1187(w),1123(w),1070(w),1034(w),867(m),830(s),798(m),770(w)cm-1;1H NMR(400MHz,CDCl3)δ8.82(1H,d,J=3.0Hz),8.03(1H,d,J=8.2Hz),7.98(1H,d,J=8.9Hz),7.58(1H,dd,J=1.96,8.8Hz),7.51(1H,d,J=1.8Hz),7.38–7.35(1H,m);13C NMR(101MHz,CDCl3)δ149.6,146.6,137.6,134.9,129.7,129.1,128.9,122.4,121.8,15.5–14.8(m,C-D3);HRMS(ESI+)[M+H]+计算值C10H7D3NS:179.0717,实测值:179.0721。
应用实施例13.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的4-碘苯基-4-甲苯磺酸酯、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以89%的分离收率得到白色固体目标产物,且氘化率>99%。M.p.=78.2–79.0℃;IR(thinfilm)1488(m),1372(s),1176(s),1155(s),1091(m),1012(w),859(m),841(m),816(s),750(m),686(m),666(m)cm-1;1H NMR(400MHz,CDCl3)δ7.68(2H,d,J=7.8Hz),7.30(2H,d,J=8.0Hz),7.12(2H,d,J=8.7Hz),6.88(2H,d,J=8.8Hz),2.44(3H,s);13C NMR(101MHz,CDCl3)δ147.0,145.5,137.7,132.2,129.8,128.6,127.3,122.8,21.8,15.6–14.8(m,C-D3);HRMS(ESI+)[M+H]+计算值C14H12D3O3S2:298.0645,实测值:298.0650。
应用实施例14.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的4-碘苯酚、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以84%的分离收率得到无色油状液体目标产物,且氘化率>99%。1H NMR(400MHz,CDCl3)δ7.22(2H,d,J=8.7Hz),6.79(2H,d,J=8.6Hz),4.79(H,s);13C NMR(101MHz,CDCl3)δ154.1,130.4,128.9,116.2,17.8–17.0(m,C-D3)。
应用实施例15.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的5-氯-2-碘吡啶、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干的甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用沙星漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以70%的分离收率得到黄色油状液体目标产物,且氘化率>99%。IR(thin film)1568(m),1451(s),1354(m),1122(s),1005(m),818(m)cm-1;1H NMR(400MHz,CDCl3)δ8.37(1H,d,J=2.4Hz),7.43(1H,d,J=7.4,13.4Hz),7.10(1H,d,J=8.6Hz);13C NMR(101MHz,CDCl3)δ158.2,148.1,135.7,127.6,122.2,13.4–12.5(m,C-D3);HRMS(ESI+)[M+H]+计算值C6H3D3ClNS:163.0171,实测值:163.0181。
应用实施例16.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的1-(烯丙基氧基)-4-碘苯、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干的、甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以37%的分离收率得到黄色油状液体目标产物,且氘化率>99%。IR(thin film)1595(w),1492(s),1279(m),1239(s),1176(m),996(m),927(m),821(m)cm-1;1HNMR(400MHz,CDCl3)δ7.28–7.24(2H,m),6.89–6.85(2H,m),6.10–6.00(1H,m),5.41(1H,dd,J=1.6,17.2Hz),5.29(1H,dd,J=1.5,10.6Hz),4.52(2H,d,J=5.3Hz);13C NMR(101MHz,CDCl3)δ157.2,133.2,130.1,129.0,117.9,115.5,69.0,17.7–16.9(m,C-D3);HRMS(ESI+)[M+H]+计算值C10H9D3OS:184.0870,实测值:184.0879。
应用实施例17.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.375mmol的氘代试剂、0.25mmol的4-碘苯胺、0.00625mmol的醋酸镍、0.0075mmol的2,2-联吡啶和0.5mmol的锌粉,在氮气或氩气氛围下抽换气三次,加入1.25mL的超干甲醇,于60℃下搅拌反应2h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃3次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以79%的分离收率得到黄色油状液体目标产物,且氘化率>99%。IR(thin film)3347(w),1619(m),1494(s),1276(m),1178(w),819(m)cm-1;1H NMR(400MHz,CDCl3)δ7.18(2H,d,J=8.4Hz),6.63(2H,d,J=8.4Hz),3.65(2H,brs);13C NMR(101MHz,CDCl3)δ145.2,131.1,125.7,115.8,18.7–17.7(m,C-D3);HRMS(ESI+)[M+H]+计算值C7H6D3NS:143.0717,实测值:143.0725。
应用实施例18.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.75mmol的氘代试剂、0.50mmol的1-乙炔基-4-甲氧基苯、0.025mmol的碘化亚铜、0.03mmol的4,5-双二苯基膦-9,9-二甲基氧杂蒽和0.75mmol的碳酸钾,在氮气或氩气氛围下抽换气三次,加入5.0mL的超干二甲基亚砜,于室温下搅拌反应24h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以90%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thinfilm)1604(m),1505(s),1288(m),1245(s),1171(s),1106(m),1030(s),829(s),781(m)(s)cm-1;1H NMR(400MHz,CDCl3)δ7.37(2H,d,J=8.8Hz),6.82(2H,d,J=8.8Hz),3.79(3H,s);13C NMR(101MHz,CDCl3)δ159.6,133.4,115.5,113.9,91.5,79.0,55.3,19.5–18.2(m,C-D3);HRMS(ESI+)[M+H]+计算值C10H8D3OS:182.0713,实测值:182.0716。
应用实施例19.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.75mmol的氘代试剂、0.50mmol的1-溴-4-乙炔苯、0.025mmol的碘化亚铜、0.03mmol的4,5-双二苯基膦-9,9-二甲基氧杂蒽和0.75mmol的碳酸钾,在氮气或氩气氛围下抽换气三次,加入5.0mL的超干二甲基亚砜,于室温下搅拌反应24h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以85%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)2165(m),1483(s),1240(w),1069(m),1009(m),820(s),768(m)cm-1;1HNMR(400MHz,CDCl3)δ7.41(2H,d,J=8.5Hz),7.25(2H,d,J=8.5Hz);13C NMR(101MHz,CDCl3)δ132.9,131.6,122.4,122.3,90.8,82.5,19.2–18.3(m,C-D3);HRMS(ESI+)[M+H]+计算值C9H5D3BrS:229.9713,实测值:229.9701。
应用实施例20.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.75mmol的氘代试剂、0.50mmol的1-氯-4-乙炔苯、0.025mmol的碘化亚铜、0.03mmol的4,5-双二苯基膦-9,9-二甲基氧杂蒽和0.75mmol的碳酸钾,在氮气或氩气氛围下抽换气三次,加入5.0mL的超干二甲基亚砜,于室温下搅拌反应24h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以83%的分离收率得到无色油状液体目标产物,且氘化率>99%。1HNMR(400MHz,CDCl3)δ7.33(2H,d,J=8.6Hz),7.26(2H,d,J=8.6Hz);13C NMR(101MHz,CDCl3)δ134.1,132.7,128.7,122.0,90.8,82.3,19.1–18.4(m,C-D3)。
应用实施例21.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.75mmol的氘代试剂、0.50mmol的1-(4-乙基苯基)乙烷-1-酮、0.025mmol的碘化亚铜、0.03mmol的4,5-双二苯基膦-9,9-二甲基氧杂蒽和0.75mmol的碳酸钾,在氮气或氩气氛围下抽换气三次,加入5.0mL的超干二甲基亚砜,于室温下搅拌反应24h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以88.2%的分离收率得到黄色固体目标产物,且氘化率>99%。M.p.=51.5–52.4℃;IR(thin film)2162(w),1674(s),1596(m),1402(m),1354(m),1265(m),1180(m),959(m),830(s),724(m)cm-1;1H NMR(400MHz,CDCl3)δ7.84(2H,d,J=8.5Hz),7.41(2H,d,J=8.5Hz),2.55(3H,s);13CNMR(101MHz,CDCl3)δ197.3,135.7,131.0,128.3,128.3,91.5,85.6,26.6,19.2–18.3(m,C-D3);HRMS(ESI+)[M+H]+计算值C11H8D3OS:194.0713,实测值:194.0708。
应用实施例22.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.75mmol的氘代试剂、0.50mmol的4-乙炔基苯甲酸甲酯、0.025mmol的碘化亚铜、0.03mmol的4,5-双二苯基膦-9,9-二甲基氧杂蒽和0.75mmol的碳酸钾,在氮气或氩气氛围下抽换气三次,加入5.0mL的超干二甲基亚砜,于室温下搅拌反应24h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以90%的分离收率得到白色固体目标产物,且氘化率>99%。M.p.=96.2–96.7℃;IR(thin film)2158(w),1706(s),1600(m),1435(m),1309(w),1275(s),1194(m),1176(m),1111(m),1001(w),960(w),853(m),768(s),698(m)cm-1;1H NMR(400MHz,CDCl3)δ7.95(2H,d,J=8.4Hz),7.42(2H,d,J=8.5Hz),3.90(3H,s);13C NMR(101MHz,CDCl3)δ166.5,130.8,129.5,129.0,128.1,91.4,85.0,52.2,19.2–18.3(m,C-D3);HRMS(ESI+)[M+H]+计算值C11H8D3OS:210.0656,实测值:210.0663。
应用实施例23.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.75mmol的氘代试剂、0.50mmol的4-乙炔基苯胺、0.025mmol的碘化亚铜、0.03mmol的4,5-双二苯基膦-9,9-二甲基氧杂蒽和0.75mmol的碳酸钾,在氮气或氩气氛围下抽换气三次,加入5.0mL的超干二甲基亚砜,于室温下搅拌反应24h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以89%的分离收率得到黄色油状液体目标产物,且氘化率>99%。IR(thin film)3371(w),1603(s),1508(s),1287(m),1175(m),1003(w),827(s)cm-1;1HNMR(400MHz,CDCl3)δ7.23(2H,dd,J=8.7,2.0Hz),6.55(2H,dd,J=8.6,2.0Hz),3.81(2H,brs);13C NMR(101MHz,CDCl3)δ146.9,133.5,114.7,112.5,92.3,77.8,19.4–18.6(m,C-D3);HRMS(ESI+)[M+H]+计算值C9H7D3NS:167.0717,实测值:167.0711。
应用实施例24.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.75mmol的氘代试剂、0.50mmol的丁-3-炔-1-基4-溴苯甲酸乙酯,0.025mmol的碘化亚铜、0.03mmol的4,5-双二苯基膦-9,9-二甲基氧杂蒽和0.75mmol的碳酸钾,在氮气或氩气氛围下抽换气三次,加入5.0mL的超干二甲基亚砜,于室温下搅拌反应24h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以66%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)1720(s),1590(m),1397(w),1265(s),1173(m),1102(s),1068(m),1011(s),847(m),754(s),682(w)cm-1;1H NMR(400MHz,CDCl3)δ7.91(2H,d,J=8.6Hz),7.59(2H,d,J=8.6Hz),4.40(2H,t,J=6.8Hz),2.77(2H,t,J=6.9Hz);13C NMR(101MHz,CDCl3)δ165.7,131.9,131.3,129.0,128.4,88.3,72.6,63.1,20.7,19.0–18.6(m,C-D3);HRMS(ESI+)[M+H]+计算值C12H9D3BrO2S2:301.9924,实测值:301.9921。
应用实施例25.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.75mmol的氘代试剂、0.50mmol的丁-3-炔-1-基4-碘苯甲酸乙酯、0.025mmol的碘化亚铜、0.03mmol的4,5-双二苯基膦-9,9-二甲基氧杂蒽和0.75mmol的碳酸钾,在氮气或氩气氛围下抽换气三次,加入5.0mL的超干二甲基亚砜,于室温下搅拌反应24h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以62%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)1717(s),1585(m),1393(m),1263(s),1176(m),1101(s),1006(s),845(m),751(s),682(m)cm-1;1H NMR(400MHz,CDCl3)δ7.79(2H,d,J=8.5Hz),7.73(2H,d,J=8.6Hz),4.38(2H,t,J=6.8Hz),2.75(2H,t,J=6.8Hz);13C NMR(101MHz,CDCl3)δ165.9,137.8,131.1,129.5,101.0,88.3,72.6,63.1,20.7,18.9–18.1(m,C-D3);HRMS(ESI+)[M+H]+计算值C12H9D3IO2S:349.9786,实测值:349.9786。
应用实施例26.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.75mmol的氘代试剂、0.50mmol的丁-3-炔-1-基-2-噻吩甲酸甲酯、0.025mmol的碘化亚铜、0.03mmol的4,5-双二苯基膦-9,9-二甲基氧杂蒽和0.75mmol的碳酸钾,在氮气或氩气氛围下抽换气三次,加入5.0mL的超干二甲基亚砜,于室温下搅拌反应24h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以60%的分离收率得到无色油状液体目标产物,且氘化率>99%。IR(thin film)1705(s),1524(w),1417(m),1357(w),1255(s),1094(s),860(w),747(s),719(s)(m)cm-1;1H NMR(400MHz,CDCl3)δ7.81(1H,dd,J=3.8,1.2Hz),7.57(1H,dd,J=5.0,1.3Hz),7.10(1H,dd,J=5.0,3.8Hz),4.37(2H,t,J=7.0Hz),2.75(2H,t,J=7.0Hz);13C NMR(101MHz,CDCl3)δ162.0,133.8,133.5,132.7,127.9,88.2,72.6,63.0,20.7,18.8–18.3(m,C-D3);HRMS(ESI+)[M+H]+计算值C10H8D3O2S2:230.0383,实测值:230.0384。
应用实施例27.
具体是:
将已经在120℃的烘箱内烘1–2小时的25.0mL封管,冷却后放入磁子,在氮气氛围下,抽放气三次,加入0.75mmol的氘代试剂、0.50mmol的3-乙炔基噻吩、0.025mmol的碘化亚铜、0.03mmol的4,5-双二苯基膦-9,9-二甲基氧杂蒽和0.75mmol的碳酸钾,在氮气或氩气氛围下抽换气三次,加入5.0mL的超干二甲基亚砜,于室温下搅拌反应24h,将反应液倾入30mL的水中,有机相用乙酸乙酯萃取(30mL×3),合并的有机相用水反萃5次,之后用无水硫酸钠干燥15min,然后用砂芯漏斗过滤,合并有机相,旋蒸除去溶剂。最后粗产物通过硅胶柱层析可以以92%的分离收率得到无色油状液体产物,且氘化率>99%。IR(thin film)2923(w),1354(w),1004(w),957(w),871(w),837(m),778(s),690(w),624(m)cm-1;1H NMR(400MHz,CDCl3)δ7.47(1H,dd,J=3.0,1.2Hz),7.28(1H,dd,J=4.8,1.8Hz),7.13(1H,dd,J=5.0,1.2Hz);13C NMR(101MHz,CDCl3)δ130.2,129.3,125.3,122.5,86.7,80.4,19.1–18.6(m,C-D3);HRMS(ESI+)[M+H]+计算值C7H4D3S2:158.0172,实测值:158.0175。
Claims (3)
1.S-(甲基-d3)苯硫醚类物质的合成方法,其特征在于:
步骤(1)常温下,将磺酸钠加入到容器中,再加入D3-对甲苯磺酰甲酯和有机溶剂;
所述的磺酸钠为结构式为的磺酸钠,其中取代基R1为甲基,取代位置为4位;
所述的有机溶剂浓度为0.1~1M;
反应体系中,加入的磺酸钠与D3-对甲苯磺酰甲酯的摩尔比为1.5:1,每mmol的D3-对甲苯磺酰甲酯对应加入1~10ml有机溶剂;
步骤(2)常温下反应2~10小时,反应方程式如下:
得到S-(甲基-d3)苯硫醚类物质,R2为/>
2.如权利要求1所述的S-(甲基-d3)苯硫醚类物质的合成方法,其特征在于:所述的有机溶剂为N,N-二甲基甲酰胺溶剂或N,N-二甲基乙酰胺溶剂。
3.如权利要求1所述的S-(甲基-d3)苯硫醚类物质的合成方法,其特征在于:反应在氮气或氩气保护下进行。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210899216.0A CN115057803B (zh) | 2022-07-28 | 2022-07-28 | S-(甲基-d3)苯硫醚类物质的合成方法及其应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210899216.0A CN115057803B (zh) | 2022-07-28 | 2022-07-28 | S-(甲基-d3)苯硫醚类物质的合成方法及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115057803A CN115057803A (zh) | 2022-09-16 |
| CN115057803B true CN115057803B (zh) | 2023-11-24 |
Family
ID=83207118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210899216.0A Active CN115057803B (zh) | 2022-07-28 | 2022-07-28 | S-(甲基-d3)苯硫醚类物质的合成方法及其应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115057803B (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102190587A (zh) * | 2010-03-18 | 2011-09-21 | 苏州泽璟生物制药有限公司 | 氘代甲胺及其盐的合成及生产的方法和工艺 |
| CN114478150A (zh) * | 2022-01-22 | 2022-05-13 | 浙江工业大学 | 一种s-氘代甲基-芳基磺酰硫酯类化合物及其合成方法与应用 |
| CN114634431A (zh) * | 2022-03-22 | 2022-06-17 | 浙江工业大学 | 一种含硫醚和砜基取代的烯烃类化合物的合成方法 |
-
2022
- 2022-07-28 CN CN202210899216.0A patent/CN115057803B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102190587A (zh) * | 2010-03-18 | 2011-09-21 | 苏州泽璟生物制药有限公司 | 氘代甲胺及其盐的合成及生产的方法和工艺 |
| CN114478150A (zh) * | 2022-01-22 | 2022-05-13 | 浙江工业大学 | 一种s-氘代甲基-芳基磺酰硫酯类化合物及其合成方法与应用 |
| CN114634431A (zh) * | 2022-03-22 | 2022-06-17 | 浙江工业大学 | 一种含硫醚和砜基取代的烯烃类化合物的合成方法 |
Non-Patent Citations (2)
| Title |
|---|
| Robust, scalable construction of an electrophilic deuterated methylthiolating reagent: facile access to SCD3-containing scaffolds;Xiao Xiao et al.;《Chem. Commun.》;第58卷;3015-3018 * |
| S‑(Methyl‑d3) Arylsulfonothioates: A Family of Robust, Shelf-Stable, and Easily Scalable Reagents for Direct Trideuteromethylthiolation;Yan Zhang et al.;《Organic Letters》;第24卷;6794-6799 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115057803A (zh) | 2022-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106928117B (zh) | 一种氘代芳香类有机化合物的制备方法 | |
| CN105985266B (zh) | 三氟甲硫基化试剂、制备方法及其应用 | |
| CN104945348B (zh) | 三氟甲硫基化试剂、合成方法及其应用 | |
| CN109053536B (zh) | 富电子芳烃或芳杂烃的三氟甲硒基化方法 | |
| Zhang et al. | Copper-catalyzed oxidative trifluoroethoxylation of aryl boronic acids with CF3CH2OH | |
| CN110452141A (zh) | 一种无过渡金属催化合成二芳基硫醚类化合物的方法 | |
| CN104945304B (zh) | 三氟甲硫基芳烃类或杂芳烃类化合物及其制备方法 | |
| CN104744394B (zh) | 一种不对称合成含三氟甲基手性季碳化合物的方法 | |
| CN115057803B (zh) | S-(甲基-d3)苯硫醚类物质的合成方法及其应用 | |
| CN104945294B (zh) | 含三氟甲硫基的化合物及其制备方法 | |
| CN113302172B (zh) | 手性四芳基甲烷的对映选择性制备方法 | |
| CN104447557B (zh) | 一种n‑芳基吡唑类化合物和n‑芳基咪唑类化合物的制备方法 | |
| CN114634482B (zh) | 一种重氮二氟甲基化试剂及其合成方法和应用 | |
| CN105985280A (zh) | 二氟甲硫基化试剂、其制备方法及应用 | |
| Liu et al. | Synthesis of α-alkynyl perfluoroalkyl sulfoxides by the reaction of terminal alkynes and perfluoroalkanesulfinyl chlorides | |
| CN105523873A (zh) | 含氟三元环化合物、其制备方法及氟烷基锍盐的制备方法 | |
| CN112457340A (zh) | 一种三/二氟乙醇化试剂及其制备方法与应用 | |
| CN101878197B (zh) | 3-巯基苯胺化合物的制备方法 | |
| CN111807938A (zh) | 一种(e)-1-氯-2-碘乙烯类化合物及其制备方法 | |
| CN114957086B (zh) | N-三氟甲基磺酰邻苯二甲酰亚胺合成方法及应用 | |
| CN110078651A (zh) | 一种新型的多取代3,3’-联吡咯化合物的制备方法 | |
| CN115710206B (zh) | 三氟甲基亚砜试剂的合成方法及应用 | |
| CN113004178A (zh) | 一种(e)-3-甲硫基-2-碘丙烯酸酯化合物的合成方法 | |
| CN114044751A (zh) | 一种氘代二氟甲硫基试剂及其制备方法和在药物分子中引入scf2d基团的方法 | |
| CN106565666A (zh) | 一种噻吩类化合物的芳基化方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |